The global innovative biopharma industry has historically been led by large multinational players with headquarters in the United States, Europe and Japan. Biopharma companies based in other countries ...

The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...

After 80 years of fruitless struggle by human mathematicians, a major geometry conjecture has at last been solved—via a straightforward query to a chatbot. “No previous AI-generated proof has come ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred When four companies control 85% of medications, ...

TORONTO — Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

After more than a year of threatening tariffs on pharmaceuticals, the Trump administration announced late Thursday afternoon that it will impose 100% tariffs on some branded drugs. According to a ...

Living with Crohn’s disease doesn’t just take a toll on your body — it can put a serious strain on your wallet, too. A Crohn’s & Colitis Foundation–led study found that people with inflammatory bowel ...

Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...

Throughout the year, Teva had momentum in innovative medicines, scaling its global generics and biosimilars portfolio. On the brand side, Teva said it continued to showcase strong performance of its ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senators introduced legislation on Thursday that would ...